The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The archive
Page 132 of 170 of this archive, newest first.
The supply gap as a clinical event
Why the reason for stopping changes what happens afterwards.
Which results are findings and which are consequences of the weight loss
Three different explanations for the same abnormal number, and how to tell them apart.
Twenty-eight days is a number from somebody else’s product
We set out what is known, what is inferred and what is simply assumed about the fortnight after a vial is opened.
Shenzhen export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
New Zealand declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The online reseller trading as Adamant Research Supply closes after 5 years
A proper account of an operation that existed, and of what closing it cost.
The 11-day notice: how a compounding wind-down works in Switzerland
The document is four pages. Three of them are about dates.
Retest date, expiry date, and the two conventions being confused
What happens to traceability when bulk material is subdivided, repackaged and relabelled two or three times before sale.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 37% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A supplier suspends shipping to Switzerland after 22 consecutive customs detentions
The route did not close because of a rule about peptides.
The incretin receptors, ranked by how much we actually know about them
The receptor is expressed in more tissues than the popular account allows, and that is the whole story.
Discontinuation rates, read honestly
An effect is dose-limiting when it prevents adequate intake, prevents normal activity, or produces a risk of its own. Discomfort alone is not the test.
Xianning export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Ireland pharmacy body issues counselling standards for liraglutide initiation
The evidence base is thin and the document says so, which is to its credit.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
A named analyst is the cheapest quality signal in this trade
What the Journal asks when a document arrives unsigned, and what the answers have been.
Two sessions a week, and the evidence behind the prescription
The recommendation survives scrutiny. The reasoning offered for it frequently does not.
What changed at MKM in July, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The 19-day notice: how a compounding wind-down works in Canada
The document is four pages. Three of them are about dates.
The relabeller trading as Vantris Bio closes after 4 years
A proper account of an operation that existed, and of what closing it cost.
Independent analysis puts a SWB orforglipron lot at 97.7%, against 94.2% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Do you need the top of the ladder?
A plateau at an intermediate dose and a plateau at the maximum dose look identical from the outside and mean different things.
Randomised withdrawal is the cleanest design in this field and the least discussed
A withdrawal trial answers a narrower question than it appears to. This piece states which question.
What the new the United Arab Emirates guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
STEP 4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Turkey health authority warns on falsified semaglutide pens
Reported from the analysis, not from a warning notice.
Medutest result on a Shenzhen tirzepatide lot lands 1.0 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.